Full-Time
Posted on 4/12/2025
Data-driven insights for healthcare improvement
No salary listed
Mid
India
Komodo Health focuses on enhancing patient care and minimizing disease impact through data analysis. Their platform, known as the Healthcare Map™, provides detailed insights by examining a wide range of data related to patients, healthcare providers, and health systems. This allows various stakeholders in the healthcare sector, including life sciences companies, patient advocacy groups, healthcare practitioners, and payers, to make informed decisions that improve patient outcomes and reduce costs. Unlike many competitors, Komodo Health emphasizes a patient-centered approach, ensuring that clinical innovations are aligned with the needs of those who require them most. The company's goal is to collaborate with partners to alleviate the burden of disease and ensure that effective therapies reach the patients who need them.
Company Size
501-1,000
Company Stage
Late Stage VC
Total Funding
$514M
Headquarters
San Francisco, California
Founded
2014
Help us improve and share your feedback! Did you find this helpful?
Competitive salary & equity compensation
Full medical, dental, & vision benefits
Mobility across San Francisco & New York City Offices
Paid Family leave
Flexible working hours
Flexible PTO
Personal wellness stipend
401(k) employer match
What You Should Know:– Komodo Health launches MapLab Enterprise, a powerful, full-stack analytics platform designed to transform how Healthcare and Life Sciences organizations generate and operationalize healthcare insights.– The new platform empowers diverse teams—from data scientists to business executives—to collaborate seamlessly, accelerate time to insight, and make faster, more confident decisions based on unified healthcare data.From Months to Hours: Accelerating Insights and Reducing CostsLife Sciences teams typically face an average of seven months to generate actionable insights due to fragmented data, disconnected tools, and siloed teams. MapLab Enterprise directly addresses these challenges by providing a comprehensive analytics platform built on weekly refreshed views of over 330 million de-identified U.S. patient journeys, delivering immediate value without complex integration. By creating a unified analytics environment, MapLab Enterprise breaks down traditional barriers between data, analytics, and business teams, enabling organizations to standardize their data foundation and accelerate insight generation from months to mere hours.“With MapLab Enterprise, projects that previously took six to eight weeks and cost over $250,000 can now be completed in a matter of hours, yielding immediate and actionable insights,” said Web Sun, President and Co-Founder of Komodo Health. “This allows our customers to make strategic decisions faster, improve patient lives sooner, and gain a competitive advantage from day one.”MapLab Enterprise is deployable on demand and delivers substantial improvements across several critical dimensions:Cost Reduction & Accelerated Insights: Reduces project timelines from months to days and delivers over 50% in cost savings through tools like MapAI™ and prebuilt analytics templates.Reduces project timelines from months to days and delivers over 50% in cost savings through tools like MapAI™ and prebuilt analytics templates. Near Real-Time Actionable Insights: Weekly data refreshes and scheduled analytics can drive significant lifts in script volume (up to 45%) and engagement rates (up to 3.8x) for personalized communications.Weekly data refreshes and scheduled analytics can drive significant lifts in script volume (up to 45%) and engagement rates (up to 3.8x) for personalized communications
Komodo Health Nasdaq Data Launch NMCI for Deep Healthcare Investment Insights. by Fred Pennic 05/06/2025 Leave a Comment. What You Should Know: – Komodo Health, recognized as the Evidentiary Standard for real-world data and healthcare analytics, and Nasdaq Data today announced a significant partnership. – The collaboration will provide hedge funds, private equity firms, and venture capital firms with an unprecedented, in-depth view into the U.S. pharmaceutical and broader healthcare industries through a new dataset, the Nasdaq Medical Claims Insights (NMCI).Nasdaq Medical Claims Insights (NMCI)The newly launched Nasdaq Medical Claims Insights (NMCI) is an exclusive Nasdaq dataset sourced directly from Komodo Health’s Healthcare Map. This map stands as the most comprehensive source of de-identified, real-world data, tracking over 330 million longitudinal and real-time patient journeys across healthcare professionals (HCPs), healthcare organizations (HCOs), and various sites of care throughout the U.S.NMCI provides extensive, de-identified information on these patient journeys, encompassing details on prescriptions (Rx), specialty pharmaceuticals, clinical records, electronic health and medical records (EHR/EMR), payer information, laboratory data, and more. Importantly, the dataset does not include any personally identifiable information, ensuring privacy.Empowering Investment Decisions in the Healthcare SectorThe NMCI dataset is designed to empower market participants by enabling them to:Track key trends within the pharmaceutical and U.S
What You Should Know:– Komodo Health, a leading healthcare technology company, has announced the recipients of its 2024 Diet-Related Health (DRH) grants.– The program, funded by the Robert Wood Johnson Foundation (RWJF), provides researchers with free access to Komodo’s Healthcare Map™, a vast repository of de-identified patient data, to study the impact of diet on health outcomes.Advancing Research and Improving Health EquityThe DRH program supports diverse research projects focused on understanding the complex relationship between diet and health. The winning proposals for 2024 address a range of critical topics, including:Diabetes and Food Insecurity: Researchers at Tufts University will investigate the impact of social safety net programs and food insecurity on patients with type 2 diabetes.Researchers at Tufts University will investigate the impact of social safety net programs and food insecurity on patients with type 2 diabetes. Equity in Obesity Care: Researchers at Boston University will examine how new anti-obesity medications are impacting treatment utilization and access among different subgroups.Researchers at Boston University will examine how new anti-obesity medications are impacting treatment utilization and access among different subgroups. Nutritional Support for Lung Cancer Patients: Oregon State University researchers will study the relationship between nutritional support and survival in lung cancer patients, with a focus on health equity.Oregon State University researchers will study the relationship between nutritional support and survival in lung cancer patients, with a focus on health equity. Urologic Disease and Obesity: Researchers at SUNY Downstate will investigate the links between obesity and urologic conditions, the impact of weight loss interventions, and racial disparities in treatment access.Researchers at SUNY Downstate will investigate the links between obesity and urologic conditions, the impact of weight loss interventions, and racial disparities in treatment access. Computer-Aided Diabetes Care: The Ohio State University Wexner Medical Center will develop AI-powered tools to identify risk factors for diabetes complications and evaluate preventive therapies.“We’re excited to offer researchers access to Komodo’s platform to explore how diet influences health outcomes across various diseases and conditions,” said Web Sun, President and Co-Founder, Komodo Health
Komodo Health launches National Drug Projections for real-time prescription trends.
Komodo Health welcomes Daniel Brox as General Manager of Analytics Consulting.